Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Allervax Cat moves towards commercialization

Jan. 8, 1997

SangStat files for U.S. marketing approval of Thymoglobulin

Jan. 7, 1997

New AIDS vaccine candidates reported by Institut Pasteur

Jan. 3, 1997

Immunomodulatory effects of ranitidine assessed in patient studies

Jan. 2, 1997

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Connaught describes potential acellular pertussis vaccines

Dec. 24, 1996

Anti-CD2 MAb enters phase II for GVHD

Dec. 23, 1996

Autoimmune disease Rx enters clinical trials

Dec. 20, 1996

Antex to be issued patent covering H. influenzae proteins

Dec. 19, 1996

Positive results reported for group A Streptococcus vaccine

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...